retatrutide phase 2 trial obesity nejm 2023 triple agonist just delivered the first top-line 3 results for a in — and the findings from TRIUMPH-4 are striking👇 Retatrutide study sees significant weight

These tend to be places where you can easily access the subcutaneous (fatty areas) under the skin and the needle will not come too close to muscle or bone

Even the oral version is not a magic pill, he said

Longterm maintenance may include: Periodic checkins to monitor weight, labs, and wellness Ongoing coaching around nutrition, exercise, and stress Additional vitamin or wellness therapies as needed Coordination with your primary care provider or specialists By staying engaged with your care team, you can address small setbacks before they become major reversals

But the finished product has not been tested in a rigorous clinical trial designed to measure GLP-1 levels, appetite changes, or weight outcomes against a placebo

The goal is to improve the plan so weight loss is healthier and more sustainable

These arent just metabolic medications that happen to help with weight